Significant Ownership of Frazier Life Sciences IX, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Frazier Life Sciences IX, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Seattle, WA
- Manager signature
- /s/ Jennifer Martin - By Jennifer Martin, CFO of FHMLS IX, L.L.C., GP of FHMLS IX, L.P., GP of Frazier Life Sciences IX, L.P.
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Frazier Life Sciences IX, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Frazier Life Sciences IX, L.P.
Significant Ownership of Frazier Life Sciences IX, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS, INC. | Common Stock, par value $0.0001 per share | 6.8% | $324,522,832 | +$29,477,804 | 4,108,404 | +10% | Patrick J. Heron | 23 Jan 2026 |
Schedules 13D/G Reported by Frazier Life Sciences IX, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.